Abdoulaye Karaboué

机构：Université Paris-Saclay, Laboratoire d'études sur les monothéismes, Groupe Hospitalier Intercommunal Le Raincy Montfermeil · ORCID：0000-0003-2074-2557

发表论文 75 篇 · 总被引 1702 次 · h-index 22

代表论文

• Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer (2022 · Cancers · 被引 99)
• Why does circadian timing of administration matter for immune checkpoint inhibitors’ efficacy? (2024 · British Journal of Cancer · 被引 95)
• Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis (2024 · ESMO Open · 被引 89)
• Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial (2020 · Cancer Medicine · 被引 70)
• Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study (2025 · EBioMedicine · 被引 46)
• Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial (2020 · International Journal of Cancer · 被引 35)